Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication ...

Shares of Hims & Hers have more than doubled this year after the company began offering compounded GLP-1 weight-loss ...